AzTrials
AzTrials

Renal StoneNCT06879990

Retrograde Saline Irrigation During Supine Mini Percutaneous Nephrolithotomy

A study testing Retrograde normal saline irrigation and Without Retrograde normal saline irrigation in people with Renal Stone and Supine Mini Percutaneous Nephrolithotomy, run by Kafrelsheikh University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This minimally invasive surgery allows us to remove kidney stones through tiny incisions and provides patients with quicker and smoother recoveries Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Retrograde normal saline irrigation and Without Retrograde normal saline irrigation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
1 siteEgypt
Study dates
1 Jan 2024to 31 Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • age above 18 years
  • renal stones

Who cannot join

  • age less than 18 years

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Elsayed Abdelhalim

    Kafr ash Shaykh, State, 44749

Other trials in Egypt

About this study

Official title: The Role of Retrograde Saline Irrigation Through Double Lumen Ureteric Catheter During Supine Mini-percutanous Nephrolithotomy for Renal Stones Extraction:a Prospective Controlled Trial

This minimally invasive surgery allows us to remove kidney stones through tiny incisions and provides patients with quicker and smoother recoveries

Being tested
Retrograde normal saline irrigation, Without Retrograde normal saline irrigation
Keywords
Supine
Medical subject headings
Nephrolithiasis, Deception

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Retrograde normal saline irrigationBehavioural

    Retrograde normal saline irrigation during supine Mini percutaneous nephrolithotomy

  • Without Retrograde normal saline irrigationBehavioural

    Without Retrograde normal saline irrigation during supine Mini percutaneous nephrolithotomy

Study groups in NCT06879990
Study groupRoleWhat they receive
Supine mini percutaneous nephrolithotomy with irrigationExperimentalNot described
Receives: Behavioral: Retrograde normal saline irrigation
Supine mini percutaneous nephrolithotomy without irrigationExperimentalNot described
Receives: Behavioral: Without Retrograde normal saline irrigation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Stone free rate

    No stone residual fragments

    Measured: two weeks from primary procedure

Secondary outcomes (2)
  1. Assess operative time

    Assess operative time in minutes

    Measured: During procedure

  2. Post operative complication

    Complication may occur post operative like fever , sever pain

    Measured: Up to 48 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Mar 2025
  2. Study start1 Jan 2024
  3. Primary completion31 Dec 2024
  4. Study completion31 Dec 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
200 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06879990
Sponsor's protocol ID
36264PR17/1/23
Status last verified
Mar 2025
First submitted
11 Mar 2025
Last updated
19 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Retrograde normal saline irrigation and Without Retrograde normal saline irrigation in people with Renal Stone and Supine Mini Percutaneous Nephrolithotomy, run by Kafrelsheikh University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Stone free rate (time frame: two weeks from primary procedure). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in